Mariska Vos

1.8k total citations
33 papers, 1.4k citations indexed

About

Mariska Vos is a scholar working on Immunology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Mariska Vos has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Mariska Vos's work include Nuclear Receptors and Signaling (14 papers), Macrophage Migration Inhibitory Factor (12 papers) and Aortic aneurysm repair treatments (4 papers). Mariska Vos is often cited by papers focused on Nuclear Receptors and Signaling (14 papers), Macrophage Migration Inhibitory Factor (12 papers) and Aortic aneurysm repair treatments (4 papers). Mariska Vos collaborates with scholars based in Netherlands, United States and Germany. Mariska Vos's co-authors include Carlie J.M. de Vries, Thijs W.H. Pols, Hans Pannekoek, Vivian de Waard, Peter I. Bonta, Claudia M. van Tiel, Kondababu Kurakula, E. Karin Arkenbout, Goran Marinković and Anouk A.J. Hamers and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Neuroscience.

In The Last Decade

Mariska Vos

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mariska Vos Netherlands	19	679	571	446	165	157	33	1.4k
Shiliang Shen United States	14	160 0.2×	280 0.5×	483 1.1×	111 0.7×	97 0.6×	23	1.3k
Raphaël Boisgard France	25	176 0.3×	223 0.4×	661 1.5×	110 0.7×	305 1.9×	55	1.7k
Daniela Meco Italy	22	348 0.5×	136 0.2×	565 1.3×	79 0.5×	356 2.3×	44	1.5k
Keri Tate United States	13	435 0.6×	253 0.4×	676 1.5×	60 0.4×	164 1.0×	19	1.7k
Anne‐Marie Bernard France	11	591 0.9×	292 0.5×	892 2.0×	165 1.0×	456 2.9×	21	1.8k
Paul E. Zarek United States	9	1.3k 1.9×	124 0.2×	703 1.6×	98 0.6×	419 2.7×	9	2.0k
Kathë A. Stanness United States	10	282 0.4×	195 0.3×	359 0.8×	74 0.4×	228 1.5×	13	1.3k
Caroline Saucier Canada	21	320 0.5×	140 0.2×	751 1.7×	90 0.5×	412 2.6×	37	1.4k
Takeshi Yonezawa Japan	23	206 0.3×	264 0.5×	554 1.2×	124 0.8×	140 0.9×	86	1.9k

Countries citing papers authored by Mariska Vos

Since Specialization

Citations

This map shows the geographic impact of Mariska Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariska Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariska Vos more than expected).

Fields of papers citing papers by Mariska Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariska Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariska Vos. The network helps show where Mariska Vos may publish in the future.

Co-authorship network of co-authors of Mariska Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Mariska Vos. A scholar is included among the top collaborators of Mariska Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariska Vos. Mariska Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mieremet, Arnout, Bernd H. Northoff, Hung‐Jen Chen, et al.. (2023). Exploring the expression and potential function of follicle stimulating hormone receptor in extragonadal cells related to abdominal aortic aneurysm. PLoS ONE. 18(5). e0285607–e0285607. 3 indexed citations

Scheithauer, Torsten P. M., Elena Rampanelli, Hilde Herrema, et al.. (2022). Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes. Diabetologia. 65(10). 1721–1733. 10 indexed citations

Vos, Mariska, Roelof Ottenhoff, Aldo Jongejan, et al.. (2021). Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity. Metabolism. 121. 154815–154815. 18 indexed citations

Pol, Vera van de, Mariska Vos, Marco C. DeRuiter, et al.. (2019). LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway. Vascular Pharmacology. 125-126. 106634–106634. 14 indexed citations

Vos, Mariska, Timo Rademakers, Marijke J. E. Kuijpers, et al.. (2019). LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis. Haematologica. 105(6). 1677–1685. 4 indexed citations

Koenis, Duco S., Lejla Medzikovic, Mariska Vos, et al.. (2018). Nur77 variants solely comprising the amino-terminal domain activate hypoxia-inducible factor-1α and affect bone marrow homeostasis in mice and humans. Journal of Biological Chemistry. 293(39). 15070–15083. 11 indexed citations

Puijvelde, Gijs H.M. van, Amanda C. Foks, Ilze Bot, et al.. (2018). CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice. PLoS ONE. 13(1). e0190962–e0190962. 13 indexed citations

Made, Ingeborg van der, et al.. (2018). Renal cystic disease in the Fbn1C1039G/+ Marfan mouse is associated with enhanced aortic aneurysm formation. Cardiovascular Pathology. 38. 1–6. 8 indexed citations

Jeanneteau, Freddy, Christian Barrère, Mariska Vos, et al.. (2018). The Stress-Induced Transcription Factor NR4A1 Adjusts Mitochondrial Function and Synapse Number in Prefrontal Cortex. Journal of Neuroscience. 38(6). 1335–1350. 55 indexed citations

10.

Pols, Thijs W.H., et al.. (2017). Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLoS ONE. 12(5). e0176715–e0176715. 107 indexed citations

11.

Hamers, Anouk A.J., Laura S. van Dam, José Duarte, et al.. (2015). Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages. PLoS ONE. 10(8). e0133598–e0133598. 53 indexed citations

12.

Kurakula, Kondababu, Mariska Vos, Goran Marinković, et al.. (2014). The LIM-Only Protein FHL2 Reduces Vascular Lesion Formation Involving Inhibition of Proliferation and Migration of Smooth Muscle Cells. PLoS ONE. 9(4). e94931–e94931. 21 indexed citations

13.

Marinković, Goran, Jeffrey Kroon, Mark Hoogenboezem, et al.. (2014). Inhibition of GTPase Rac1 in Endothelium by 6-Mercaptopurine Results in Immunosuppression in Nonimmune Cells: New Target for an Old Drug. The Journal of Immunology. 192(9). 4370–4378. 40 indexed citations

14.

Jager, Saskia C.A. de, Erik S.G. Stroes, Mariska Vos, et al.. (2013). Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice. Cardiovascular Research. 101(2). 277–287. 26 indexed citations

15.

Hamers, Anouk A.J., Mariska Vos, Fadi Rassam, et al.. (2011). Bone Marrow–Specific Deficiency of Nuclear Receptor Nur77 Enhances Atherosclerosis. Circulation Research. 110(3). 428–438. 143 indexed citations

16.

Bonta, Peter I., Hanke L. Matlung, Mariska Vos, et al.. (2010). Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels. Cardiovascular Research. 87(3). 561–568. 37 indexed citations

17.

Pols, Thijs W.H., Peter I. Bonta, Nuno Pires, et al.. (2010). 6-Mercaptopurine Inhibits Atherosclerosis in Apolipoprotein E*3-Leiden Transgenic Mice Through Atheroprotective Actions on Monocytes and Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 30(8). 1591–1597. 29 indexed citations

18.

Pols, Thijs W.H., Roelof Ottenhoff, Mariska Vos, et al.. (2007). Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochemical and Biophysical Research Communications. 366(4). 910–916. 58 indexed citations

19.

Waard, Vivian de, E. Karin Arkenbout, Mariska Vos, et al.. (2006). TR3 Nuclear Orphan Receptor Prevents Cyclic Stretch-Induced Proliferation of Venous Smooth Muscle Cells. American Journal Of Pathology. 168(6). 2027–2035. 57 indexed citations

20.

Bonta, Peter I., Claudia M. van Tiel, Mariska Vos, Hans Pannekoek, & Carlie J.M. de Vries. (2006). Nuclear orphan receptors Nur77, Nurr1 and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Vascular Pharmacology. 45(3). e18–e18. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact